Berlin Metropolitan Area
Biotechnology executive with 35+ years of global experience leading innovation across discovery research, clinical development, and regulatory strategy. Currently driving rational computational peptide design and preclinical development, integrating AI, molecular modeling, and data-driven analytics to accelerate therapeutic discovery in oncology and infectious diseases. As a C-suite leader, I have guided organizations through transformation, portfolio expansion, and digital integration, combining scientific insight with strategic and operational execution. Earlier, I directed global clinical and RWE programs across biopharma and CRO sectors, advancing late-phase trials and market access initiatives. Grounded in veterinary medicine and pathology, I’m passionate about linking AI-enabled discovery with clinical impact, mentoring teams, and steering biotechnology companies toward sustainable, innovation-driven growth.
Founded and scaled a company focused on preclinical and clinical operations, business development, and operational leadership. Supported M&A activities and operational modeling for drug development. Advanced R&D strategies integrating digital innovation and real-world evidence, and partnered with digital-health startups to develop patient-centric data integration for rare-disease analytics. approaches.
RDP Pharma AG is a privately held biotechnology company committed to developing innovative therapies that address unmet medical needs in oncology, virology, and molecular medicine. The company’s mission is to translate cutting-edge science into life-changing treatments for patients worldwide. As part of RDP’s executive leadership, I contributed to shaping the organization’s strategic direction and R&D portfolio, guiding programs from discovery to preclinical validation and IND readiness. Working with a board and leadership team composed of seasoned biotech entrepreneurs and drug-development experts, we focused on rigorous scientific evaluation, efficient experimental design, and clinical strategies aligned with regulatory and commercial objectives. This environment fostered an entrepreneurial, results-driven culture, ensuring that every project was designed to ask the right scientific questions, conduct the right experiments, and deliver the right data to accelerate patient impact.
Led global Clinical Operations and Clinical Delivery functions, overseeing research programs for CureVac’s COVID-19 vaccine, infectious disease, oncology, and molecular therapy candidates. Provided strategic direction for project management, operational execution, and scientific evaluation. Guided clinical evidence generation to support regulatory submissions and marketing authorization, ensuring alignment of timelines, quality, and organizational objectives.
Oversaw end-to-end program management across the CureVac development portfolio, from product candidate nomination through non-clinical and clinical development to regulatory dossier submission. Provided strategic oversight of timelines, budgets, and cross-functional coordination among R&D, regulatory, manufacturing, and clinical teams. Ensured scientific and operational alignment across early- and late-stage assets, driving program integration, risk management, and decision-making efficiency to accelerate development and maximize portfolio value.
As Senior Executive at Clinerion, I led strategic initiatives advancing the use of real-world evidence (RWE), electronic health records (EHR), and registry-based research to enhance clinical development and patient access. I directed cross-functional teams integrating AI and advanced analytics to transform large-scale healthcare data into actionable clinical and commercial insights. My leadership focused on bridging digital innovation and medical data science, implementing AI-assisted patient profiling systems, improving registry data quality, and supporting collaborations with global biopharma and healthcare partners. These initiatives significantly accelerated trial recruitment, improved evidence generation, and strengthened data-driven decision-making across the organization.
Led global Clinical Operations, ensuring high-quality delivery across all clinical trials conducted by the company. Oversaw operational departments worldwide, providing strategic and functional leadership to local and regional teams. Established performance frameworks, optimized trial execution processes, and strengthened collaboration between clinical, regulatory, and data-management functions. Directed M&A and due diligence activities, evaluating operational fit, scalability, and compliance of potential acquisitions. Drove post-acquisition integration and capability-building initiatives to align newly acquired entities with corporate standards of excellence and efficiency.